◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Global Health Limited (MEDANTA) EPS 2023–TTM
DATA UPDATED 2026-10-22
Global Health Limited annual earnings per share (EPS) for fiscal TTM was ₹20.68, an increase of 0.1% from ₹20.66 in fiscal 2026. All figures are reported results from public filings — no estimates or projections.
MEDANTA Annual EPS
| EPS (annual) | TTM → 2026-06-30 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|
| Diluted EPS | ₹21M | ₹21M | ₹18M | ₹18M | ₹13M |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
MEDANTA Quarterly EPS
| EPS (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|
| Diluted EPS | ₹6M | ₹5M | ₹4M | ₹6M | ₹6M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
EPS at Comparable Companies
- MAXHEALTH EPS — Max Healthcare Institute Limited
- ASTERDM EPS — Aster DM Quality Care Limited
- FORTIS EPS — Fortis Healthcare Limited
- NH EPS — Narayana Hrudayalaya Limited
- BDMS EPS — Bangkok Dusit Medical Services Public Company Limited
- KIMS EPS — Krishna Institute of Medical Sciences Limited
More MEDANTA metrics: Revenue · Gross Profit · Operating Income · Net Income · Free Cash Flow
All MEDANTA financial statements → Interactive MEDANTA charts →
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.